Abstract :
Cardiovascular disease is a class of diseases which involve the heart or blood vessels. Among Human
immunodeficiency virus (HIV) infected population, cardio-vascular disease (CVD) has been found to be the second
leading cause of death. There is an increased incidence rate and prevalence of heart diseases among HIV infected
population when compare to general population. Usually, the goal of anti-retroviral therapy (ART) is to suppress
the virus growth which in turn reduces morbidity and mortality rate by immune reconstitution but this has been
affected due to augmenting metabolic changes such as insulin resistance, dyslipidemia, inflammation, impaired
fibrinolysis or combinations of these factors etc., which occurs simultaneously with HIV infection resulting in an
increased risk of cardiovascular disease. Therefore, while making a therapeutic decision in HIV patients,
individualized therapy for each patient should be based on presence of CVD risk factors. Understanding the disease
severity and treatment will lead to successful management of CVD in AIDS patients.
Key words: HIV, Dyslipidemia, Cardiovascular disease, Anti-retroviral therapy.
Keyword :
HIV, Dyslipidemia, Cardiovascular disease, Anti-retroviral therapy.